Berapa harga Handa Pharmaceuticals, Inc. (6620)

Harga Handa Pharmaceuticals, Inc. (6620) adalah $2.95

Apa kapitalisasi pasar Handa Pharmaceuticals, Inc. (6620)

Kapitalisasi pasar Handa Pharmaceuticals, Inc. (6620) adalah $491.95M

Handa Pharmaceuticals, Inc. (6620) Rasio P/B

Handa Pharmaceuticals, Inc. operates as a specialized drug company, concentrating its efforts on creating and advancing new medications for diverse health issues across both the United States and China. The firm currently offers Quetiapine XR, a treatment for Schizophrenia, as well as Dexlansoprazole DR capsules. Beyond its existing portfolio, Handa is actively cultivating a robust pipeline of therapies. This includes their cutting-edge ONCORE drug delivery platform, engineered to boost patient adherence and improve the safety of tyrosine kinase inhibitor oncology drugs. Other significant projects encompass a 505(b)(2)NDA therapeutic agent, Tascenso ODT for managing multiple sclerosis, and the oncology candidates HND-033 and HND-027. Furthermore, the company's development initiatives feature HND-004, designed for diabetic patients; HND-032, intended to aid in smoking cessation; and HND-026, a gastrointestinal medication. Founded in 2014, Handa Pharmaceuticals, Inc. has its main corporate headquarters situated in Tainan City, Taiwan.

Tahun	Rasio P/B	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Rasio P/B

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Perusahaan	Rasio P/B	Perbedaan Rasio P/B	Negara
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5.5207	-	IN
Galderma Group AG GALD.SW	-	-	CH

Perusahaan

Rasio P/B

Perbedaan Rasio P/B

Negara